The bill H. 4545 is a concurrent resolution introduced in the South Carolina General Assembly that allows for the consideration of additional matters by the General Assembly after May 8, 2025. Specifically, it permits the introduction, receipt, and consideration of H. 4262, which pertains to the restriction, regulation, or prohibition of mRNA gene therapies. This resolution outlines that these matters can be addressed prior to the sine die adjournment, including actions such as concurrence, nonconcurrence, and the appointment of conferees, as well as the receipt and disposition of conference reports and any applicable vetoes.

The resolution emphasizes the flexibility of the legislative process by expanding the scope of issues that can be addressed during the remaining session. It aims to ensure that the General Assembly can effectively manage and deliberate on significant health-related legislation concerning mRNA gene therapies, thereby facilitating timely legislative action on this topic.